CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Material agreement · Unregistered share sale
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Material agreement · Agreement ended
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Executive or director change · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Agreement ended
- 8-K Event Material agreement
Page 6 of 12 · 239 filings